Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study ; volume:10 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-10 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (12.9.2018), 1-10, 12.2018
- Creator
-
Mouton, A.
- Contributor
-
Blanc, F.
Gros, A.
Manera, V.
Fabre, R.
Sauleau, E.
Gomez-Luporsi, I.
Tifratene, K.
Friedman, L.
Thümmler, S.
Pradier, C.
Robert, P. H.
David, R.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0417-4
- URN
-
urn:nbn:de:101:1-2018102823501623372039
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mouton, A.
- Blanc, F.
- Gros, A.
- Manera, V.
- Fabre, R.
- Sauleau, E.
- Gomez-Luporsi, I.
- Tifratene, K.
- Friedman, L.
- Thümmler, S.
- Pradier, C.
- Robert, P. H.
- David, R.
- SpringerLink (Online service)
Other Objects (12)
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Presenilins in Alzheimer’s disease and frontotemporal dementia